Chase AIPricingFAQs
Display currency
Loading news…

Novelty Nobility

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Seongnam, Kyonggi-do, South Korea Founded 2017 11-50 employees For Profit

Novelty Nobility is a biotech company that focuses on research of novel angiogenesis targets and develop antibody-based therapeutics.

Novelty Nobility was acquired by Koas in 2025.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
2
Patents
16

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
Patents granted
16
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2017
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
8
HQ
Seongnam, Kyonggi-do, South Korea
Region
Asia-Pacific (APAC)
Exit date
Aug 26, 2025

Signals & Scores

Heat score
Medium
Growth score
High
Trend (7d)
-0.4
Trend (30d)
-2.9
Trend (90d)
0
Last leadership hire
Feb 25, 2026
2
professional contacts at Novelty Nobility
Contact execs at Novelty Nobility

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Novelty Nobility

Loading news…

FAQs about Novelty Nobility

People who checked this page also checked these

Browse the full Acquirezy directory.
Novelty Nobility - Company Profile, Full Acquisitions List, Funding and Investments